TECHNOLOGY:  

Rapid Infection Detection using CAPTURE™ (Confirm Active Pathogens Through Unamplified RNA Expression)

AFFILIATION:   GeneCapture, Inc., Huntsville, Alabama, United States

TECHNOLOGY SUMMARY

Track: Medical & Biotech
Area: Infectious Disease
Tech Readiness: TRL 5

Tech Brief: Using a rapid genetic signature match, our portable instrument will screen for up to 200 pathogens from a human sample, in less than an hour, and for less than $20 in consumable costs.

FIGURES OF MERIT

Value Proposition: Current methods for detecting the source of an infection in a human sample are slow, fragile and generally lab-centric. The CAPTURE technique, when accomplished in a portable instrument (CapLabX) allows: Point of Care rugged diagnostics: the CAPTURE system will allow diagnosis on the front lines. The combined Pathogen Array eliminates the burden of managing different testing panels and is stable in temperature extremes. Rapid inclusion of newly identified pathogens: GeneCapture’s DNA Captor probe design and validation techniques allow new pathogen targets to be added to the Pathogen Array in under two weeks. Combined with the handheld CapLabX, detection and identification of pathogens can be deployed rapidly with minimal infrastructure requirements. Rapid Turn-Around Time (TAT): Results in under 60 minutes allow rapid health care management and informed decision making.

SHOWCASE SUMMARY

Org Type: Mid-stage Startup (A or B)
Website: www.genecapture.com
Booth Number: W114